• An overview of the current understanding of bleeding and thrombosis in cirrhosis.• An
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …

NCPH is a heterogeneous group of liver disorders of vascular origin, leading to PHT with
near normal HVPG. NCPF/IPH is a disorder of young adults or middle aged women …

Current recommendations for early anticoagulation in acute portal vein thrombosis unrelated
to cirrhosis or malignancy are based on limited evidence. The aim of this study was to …

Myeloproliferative neoplasms (MPNs) are the most common cause of Budd-Chiari syndrome
(BCS) and nonmalignant, noncirrhotic portal vein thrombosis (PVT). In this meta-analysis …

BACKGROUND/AIMS: Portal vein thrombosis in patients with liver cirrhosis is usually
associated to hepatocellular carcinoma. Clinical presentation of non-neoplastic portal vein …

BACKGROUND/AIMS: Prognostic scores currently used in cirrhotic patients do not include
thrombotic risk factors (TRFs). Predicting factors of portal vein thrombosis (PVT) …

AIM: To assess the lifetime cumulative incidence of portal venous thrombosis (PVT) in the
general population. METHODS: Between 1970 and 1982, 23 796 autopsies, representing …

Portal vein thrombosis (PVT) is a relatively common complication in patients with liver
cirrhosis, but might also occur in absence of an overt liver disease. Several causes, either …

Liver diseases in pregnancy comprise both gestational liver disorders and acute and chronic
hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or …

Aliment Pharmacol Ther 31, 366‐374 Summary Background As current imaging techniques
in cirrhosis allow detection of asymptomatic portal vein thrombosis during routine …